Table 1.
Demographics and laboratory findings of COVID-19 patients and healthy controls.
| Parameter | G1 mean ± SD (N = 50) | G2 mean ± SD (N = 50) | G3 mean ± SD (N = 50) | Significance Level |
||
|---|---|---|---|---|---|---|
| G1 vs G2 | G1 vs G3 | G2 vs G3 | ||||
| Age (Male-Female) |
52.8 ± 15.32 (24−26) |
51.1 ± 15.2 (23−27) |
52.2 ± 12.46 (28−22) |
NS | NS | NS |
| BMI (kg/m2) | 26.29 ± 3.273 | 27.1 ± 5.261 | 27.98 ± 4.564 | NS | NS | NS |
| SBP (mmHg) | 112.8 ± 11.73 | 114.5 ± 12 | 122.6 ± 19.05 | NS | 0.0078 | 0.0390 |
| DBP (mmHg) | 72.38 ± 8.588 | 72.52 ± 8.596 | 73.42 ± 12.05 | NS | NS | NS |
| FBS (mg/dl) | 104.9 ± 23.11 | 118.3 ± 31.25 | 138.9 ± 49.95 | 0.0496 | 0.0001 | 0.0455 |
| TG (mg/dl) | 142.0 ± 55.99 | 161.8 ± 62.33 | 186.5 ± 55.31 | NS | 0.0004 | NS |
| Cholesterol (mg/dl) | 180.8 ± 42.39 | 188 ± 40.3 | 196.6 ± 34.96 | NS | NS | NS |
| HDL (mg/dl) | 44.04 ± 8.877 | 44 ± 8.52 | 42.49 ± 7.153 | NS | NS | NS |
| LDL (mg/dl) | 120.6 ± 31.52 | 131. 9 ± 24.34 | 144.9 ± 27.97 | NS | 0.0003 | 0.0434 |
| Albumin (g/dl) | 3.461 ± 0.2154 | 3.367 ± 0.3766 | 3.251 ± 0.2881 | NS | 0.0003 | NS |
| Creatinine (mg/dl) | 1.554 ± 1.043 | 1.522±.845 | 1.450 ± 0.7022 | NS | NS | NS |
| GFR (cc/min) | 77.77 ± 24.11 | 70.84 ± 25.14 | 67.47 ± 22.71 | NS | NS | NS |
| Diabetic Patients | 7 | 9 | 14 | NS | 0.00854 | 0.0192 |
| Clinically COVID-19 Positive Subjects | – | 50 | 50 | |||
Data are presented as mean ± standard devision. P < 0.05 was considered as statistically significant. G1: Healthy Controls; G2: Patients with mild symptoms; G3: Patients with severe symptoms; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBS: fasting blood sugar; TG: triglyceride; HDL: high density lipoprotein; LDL: low density lipoprotein; GFR: glomerular filtration rate.